Rapid detection of ITPA 94C>A and IVS2 + 21A>C gene mutations by real-time fluorescence PCR and in vitro demonstration of effect of ITPA IVS2 + 21A>C polymorphism on splicing efficiency

Clinical Chemistry

Volumn 50, Issue 11, 2004, Pages 2182-2184

  Heller, Tanja ^a   Oellerich, Michael ^a   Armstrong, Victor William ^a   Von Ahsen, Nicolas ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; FLUORESCEIN; INOSINE TRIPHOSPHATASE; PHOSPHATASE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; IN VITRO STUDY; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; FLUORESCENCE; GENOTYPE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PURINES; PYROPHOSPHATASES; RISK ASSESSMENT; RNA SPLICING;

EID: 7044274525     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.039685     Document Type: Article

References (10)

1. Zachara B, Lewandow J. Isolation and identification of inosine triphosphate from human erythrocytes. Biochim Biophys Acta 1974;353:253-9.
2. Sumi S, Marinaki AM, Arenas M, Fairbanks L, Shobowale-Bakre M, Rees DC, et al. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum Genet 2002;111:360-7.
3. Marinaki AM, Ansari A, Duley JA, Arenas M, Sumi S, Lewis CM, et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPA). Pharmacogenetics 2004;14:181-7.
4. Weinshilboum R. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab Dispos 2001;29:601-5.
5. Armstrong VW, Shipkova M, von Ahsen N, Oellerich M. Analytic aspects of monitoring therapy with thiopurine medications. Ther Drug Monit 2004;26:215-9.
6. Kirschner BS. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology 1998;115:813-21.
7. von Ahsen N, Oellerich M. The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system. Blood 2004;103:586-93.
8. Schwab M, Schaffeler E, Marx C, Fischer C, Lang T, Behrens C, et al. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine Smethyltransferase polymorphism. Pharmacogenetics 2002;12:429-36.
9. Lennard L, Welch JC, Lilleyman JS. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity. Br J Clin Pharmacol 1997;44:455-61.
10. Majewski J, Ott J. Distribution and characterization of regulatory elements in the human genome. Genome Res 2002;12:1827-36.